Virksomhedens formål er at bistå medicinal- og life science-virksomheder med udarbejdelse, strukturering og kvalitetssikring af lovpligtig dokumentation og myndighedsgodkendelser.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 9.1 mio. | 266 t. | 3.5 mio. | 1 mio. | 2 | |
CVR: 26686393
Secondary names: DANCAD A/S, DANCAD ENGINEERING A/S, REGULUS CONSULTING A/S
Previous names: DANCAD ENGINEERING ApS UNDER STIFTELSE, DANCAD ENGINEERING ApS, DANCAD ENGINEERING A/S
Compared to 1.148 companies in Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.
Comparison is based on industry median values
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB resigned as auditor
Companies in the same industry and area
CVR 38347551
CVR 32602479
CVR 45548198
CVR 46473493
CVR 46145798
The financial health of MEDICOLOGIC A/S shows signs of recovery and growth, with a notable increase in revenue from 6.5 million DKK in 2024 to 9.1 million DKK in 2025. Profitability has improved significantly, moving from a loss of 20,214 DKK in 2023 to a profit of 266,219 DKK in 2025, indicating a positive trajectory. Equity has also strengthened, rising from 769,051 DKK in 2024 to 1,035,270 DKK in 2025, reflecting a solid foundation for future growth. However, the company has experienced fluctuations in revenue and profit over the past few years, suggesting potential volatility in its operations. Overall, MEDICOLOGIC A/S appears to be stabilizing within the engineering consulting sector, though continued monitoring of its margins and operational efficiency will be essential.
AI-generated summary
companydata.dk